We looked at Turing, we looked at Valeant, and what we found was a pattern of certain, what I call, hedge fund pharma companies buying the rights to a drug and then, overnight, increasing the cost by as much as literally 5,000 percent in the case of Daraprim.
Senator Collins highlights drastic price hikes by pharmaceutical companies after acquiring drug rights.
Share & report
More from Susan Collins
That procedural motion does not predict my vote on final passage. I will be filing a number of amendments.
Generally, I give deference to the majority leader’s power to bring bills to the Senate floor.
Imposing tariffs on Canada, Maine’s closest trading partner, threatens jobs, drives up costs, and hurts small businesses that have long relied on cross-border cooperation and exchange.
There's some very good changes that have been made in the latest version, but I want to see further changes.
Other voices in this conversation
